Skip to search boxSkip to navigationSkip to main content

MicroRNAs as regulators of prostate cancer metastasis

  • Divya Bhagirath
    ,
  • Thao Ly Yang
    ,
  • Rajvir Dahiya
    ,
  • Sharanjot Saini(corresponding author)
*Corresponding author for this work
  • VA Medical Center
Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Prostate cancer causes significant morbidity in men and metastatic disease is a major cause of cancer related deaths. Prostate metastasis is controlled by various cellular intrinsic and extrinsic factors, which are often under the regulatory control of various metastasis-associated genes. Given the dynamic nature of metastatic cancer cells, the various factors controlling this process are themselves regulated by microRNAs which are small non-coding RNAs. Significant research work has shown differential microRNA expression in primary and metastatic prostate cancer suggesting their importance in prostate pathogenesis. We will review the roles of different microRNAs in controlling the various steps in prostate metastasis.

Publication Information

Output type

Scholary Output:
Chapter in Book/Report/Conference proceeding
Chapter

Original language

English (US)

Pages from-to (Number of pages)

Pages 83-100 (18 pages)

Publication milestones

  • Published - 2018

Publication status

Published - 2018

Publisher

Springer New York LLC

Publication series

  • Publication series name: Advances in Experimental Medicine and Biology
    ISSN (Print): 0065-2598
    ISSN (Electronic): 2214-8019
    Volume: 1095

Publication IDs

  • Scopus: 85053796343
  • PubMed: 30229550

Host publication title

Advances in Experimental Medicine and Biology

Publication metrics

Metrics

Scopus
citations
SciVal
citations
6
SciVal
FWCI
2.02
SciVal
Author count
4
SciVal
Paper percentile
70
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
0.50
Fractional count
2
Fractional count
1

PlumX, opens in new tab

Captures
14
Citation count
14

Funding Details

Acknowledgements We thank Dr. Roger Erickson for his support with preparation of the manuscript. Research in authors’ lab is supported by the National Cancer Institute at the NIH (Grant Number RO1CA177984).
FundersFunding number
NIH
RO1CA177984
NCI
-